<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">SODIUM FERRIC GLUCONATE COMPLEX</span><br/>(so'di-um fer'ric glu'co-nate)<br/><span class="topboxtradename">Ferrlecit<br/></span><b>Classifications:</b> <span class="classification">blood formers, coagulators and anticoagulants</span>; <span class="classification">iron preparation</span><br/><b>Prototype: </b>Ferrous Sulfate<br/><b>Pregnancy Category: </b>B<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>62.5 mg elemental iron/5 mL ampule</p>
<h1><a name="action">Actions</a></h1>
<p>Stable iron complex used to restore iron loss in chronic kidney failure patients. The use of erythropoietin therapy, and blood
         loss through hemodialysis requires iron replacement.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>The ferric ion combines with transferrin and is transported to bone marrow where it is incorporated into hemoglobin. Indicated
         by improved Hgb and Hct, iron saturation, serum ferritin levels.
      </p>
<h1><a name="uses">Uses</a></h1>
<p>Treatment of iron deficiency in patients on chronic hemodialysis and receiving erythropoietin therapy.</p>
<h1><a name="contrain">Contraindications</a></h1>
<p>All anemias not related to iron deficiency; hypersensitivity to sodium ferric gluconate complex; hemochromatosis, hemosiderosis;
         hemolytic anemia.
      </p>
<h1><a name="precaution">Cautious Use</a></h1>
<p>Active or suspected infection; pregnancy (category B), lactation; older adults. Safety and efficacy in children 
      </p><h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Iron Deficiency in Dialysis Patients</span><br/><span class="rdage">Adult:</span> <span class="rdroute">IV</span> 125 mg infused over 1 h<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1>
<table cellpadding="4" cellspacing="0" class="ivbox" width="100%">
<tr>
<td><span class="ivtitle">Intravenous</span><p><span class="routemethod">PREPARE:</span> <span class="methodtype">IV Infusion:</span>  Dilute 10 mL of Ferrlecit in 100 mL of NS. Use immediately after dilution.  
               </p>
<p><span class="routemethod">ADMINISTER:</span> <span class="methodtype"> IV Infusion:</span>  Give over <small>NOT LESS</small> than 60 min. Never administer at a rate greater than 2.1 mg/min.  
               </p>
<p><span class="routemethod">INCOMPATIBILITIES</span> <span class="incompattype">Solution/additive:</span> Do not mix with any other medications or add to parenteral nutrition solutions. 
               </p>
</td>
</tr>
</table>
<ul>
<li>Store unopened ampules at 20°25° C (68°77° F).</li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">Body as a Whole:</span> <span class="speceff-life">Hypersensitivity reaction (cardiovascular collapse, cardiac arrest, bronchospasm, oral/pharyngeal edema</span>, dyspnea, <span class="speceff-life">angioedema</span>, urticaria, pruritus). <span class="typehead"> CV:</span> Flushing, hypotension. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1>Not studied. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Monitor closely for S&amp;S of severe hypersensitivity (see Appendix F) during IV administration.</li>
<li>Monitor vital signs periodically during IV administration (transient hypotension possible especially during dialysis).</li>
<li>Stop infusion immediately and notify physician if hypersensitivity is suspected.</li>
<li>Lab tests: Periodic Hgb, Hct, Fe saturation, serum ferritin.</li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Report to physician immediately: Difficulty breathing, itching, flushing, rash, weakness, light-headedness, pain, or any other
            discomfort during infusion.
         </li>
<li>Do not breast feed while taking this drug without consulting physician.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>